| # | Drug | Count |
|---|---|---|
| 0 | OSIMERTINIB | 474 |
| 1 | GEFITINIB | 259 |
| 2 | DOXORUBICIN | 145 |
| 3 | LAMIVUDINE | 142 |
| 4 | LAMIVUDINE ORAL | 142 |
| 5 | PREDNISOLONE | 127 |
| 6 | PREDNISOLONE ORAL | 127 |
| 7 | PREDNISOLONE ORAL SOLUTION | 127 |
| 8 | RITUXIMAB | 115 |
| 9 | CYCLOPHOSPHAMIDE | 111 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GEFITINIB | 259 | 0.0288 |
| 1 | AFATINIB | 38 | 0.0057 |
| 2 | LAMIVUDINE | 142 | 0.0056 |
| 3 | NEVIRAPINE | 50 | 0.0056 |
| 4 | ERLOTINIB HYDROCHLORIDE | 66 | 0.0053 |
| 5 | ZIDOVUDINE | 45 | 0.0043 |
| 6 | SONIDEGIB | 7 | 0.0042 |
| 7 | DASATINIB | 38 | 0.0041 |
| 8 | TENOFOVIR DISOPROXIL FUMARATE TABLETS | 35 | 0.0040 |
| 9 | PLATINUM | 2 | 0.0038 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 149 | 0.0030 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 57 | 0.0024 |
| 2 | Poly(ADP-Ribose) Polymerase Inhibitor [EPC] | 40 | 0.0019 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 164 | 0.0015 |
| 4 | Kinase Inhibitor [EPC] | 671 | 0.0012 |
| 5 | Aldehyde Dehydrogenase Inhibitor [EPC] | 1 | 0.0009 |
| 6 | CCR5 Co-receptor Antagonist [EPC] | 2 | 0.0009 |
| 7 | Estrogen Receptor Antagonist [EPC] | 31 | 0.0008 |
| 8 | Hedgehog Pathway Inhibitor [EPC] | 7 | 0.0007 |
| 9 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 64 | 0.0006 |